181 related articles for article (PubMed ID: 27806598)
21. Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma.
Chawla S; Bukhari S; Afridi OM; Wang S; Yadav SK; Akbari H; Verma G; Nath K; Haris M; Bagley S; Davatzikos C; Loevner LA; Mohan S
NMR Biomed; 2022 Jul; 35(7):e4719. PubMed ID: 35233862
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of Glioblastoma Multiforme Progression via Interpretable Structure-Constrained Graph Neural Networks.
Song X; Li J; Qian X
IEEE Trans Med Imaging; 2023 Feb; 42(2):380-390. PubMed ID: 36018877
[TBL] [Abstract][Full Text] [Related]
23. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
[TBL] [Abstract][Full Text] [Related]
24. Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis.
Sidibe I; Tensaouti F; Gilhodes J; Cabarrou B; Filleron T; Desmoulin F; Ken S; Noël G; Truc G; Sunyach MP; Charissoux M; Magné N; Lotterie JA; Roques M; Péran P; Cohen-Jonathan Moyal E; Laprie A
Radiother Oncol; 2023 Apr; 181():109486. PubMed ID: 36706959
[TBL] [Abstract][Full Text] [Related]
25. Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas.
de Godoy LL; Mohan S; Wang S; Nasrallah MP; Sakai Y; O'Rourke DM; Bagley S; Desai A; Loevner LA; Poptani H; Chawla S
J Transl Med; 2023 Apr; 21(1):287. PubMed ID: 37118754
[TBL] [Abstract][Full Text] [Related]
26. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
27. Morphometric model for discrimination between glioblastoma multiforme and solitary metastasis using three-dimensional shape analysis.
Yang G; Jones TL; Howe FA; Barrick TR
Magn Reson Med; 2016 Jun; 75(6):2505-16. PubMed ID: 26173745
[TBL] [Abstract][Full Text] [Related]
28. Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
Hagiwara A; Schlossman J; Shabani S; Raymond C; Tatekawa H; Abrey LE; Garcia J; Chinot O; Saran F; Nishikawa R; Henriksson R; Mason WP; Wick W; Cloughesy TF; Ellingson BM
J Neurooncol; 2022 Sep; 159(3):509-518. PubMed ID: 35842871
[TBL] [Abstract][Full Text] [Related]
29. Discrimination between glioblastoma multiforme and solitary metastasis using morphological features derived from the p:q tensor decomposition of diffusion tensor imaging.
Yang G; Jones TL; Barrick TR; Howe FA
NMR Biomed; 2014 Sep; 27(9):1103-11. PubMed ID: 25066520
[TBL] [Abstract][Full Text] [Related]
30. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
31. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
[TBL] [Abstract][Full Text] [Related]
32. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme.
Patel V; Hathout L
Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
34. Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
Bhandari A; Marwah R; Smith J; Nguyen D; Bhatti A; Lim CP; Lasocki A
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):781-797. PubMed ID: 35599360
[TBL] [Abstract][Full Text] [Related]
35. Morphologic MRI features, diffusion tensor imaging and radiation dosimetric analysis to differentiate pseudo-progression from early tumor progression.
Agarwal A; Kumar S; Narang J; Schultz L; Mikkelsen T; Wang S; Siddiqui S; Poptani H; Jain R
J Neurooncol; 2013 May; 112(3):413-20. PubMed ID: 23417357
[TBL] [Abstract][Full Text] [Related]
36. Discriminative analysis of multivariate features from structural MRI and diffusion tensor images.
Li M; Qin Y; Gao F; Zhu W; He X
Magn Reson Imaging; 2014 Oct; 32(8):1043-51. PubMed ID: 24970026
[TBL] [Abstract][Full Text] [Related]
37. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
Front Immunol; 2021; 12():790674. PubMed ID: 34899760
[TBL] [Abstract][Full Text] [Related]
38. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences.
Wang W; Tugaoen JD; Fadda P; Toland AE; Ma Q; Elder JB; Giglio P; ; Otero JJ
Acta Neuropathol Commun; 2023 Dec; 11(1):192. PubMed ID: 38049893
[TBL] [Abstract][Full Text] [Related]
40. Classification of cancer cells using computational analysis of dynamic morphology.
Hasan MR; Hassan N; Khan R; Kim YT; Iqbal SM
Comput Methods Programs Biomed; 2018 Mar; 156():105-112. PubMed ID: 29428061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
